TG Therapeutics, Inc. (TGTX)
54.29
+0.67
(+1.25%)
USD |
NASDAQ |
Oct 02, 16:00
54.27
-0.02
(-0.04%)
After-Hours: 20:00
TG Therapeutics Profit Margin (Quarterly) : 3.24% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.24% |
| March 31, 2026 | 9.65% |
| December 31, 2025 | 11.96% |
| September 30, 2025 | |
| June 30, 2025 | 19.97% |
| March 31, 2025 | 4.19% |
| December 31, 2024 | 21.56% |
| September 30, 2024 | 4.63% |
| June 30, 2024 | 9.36% |
| March 31, 2024 | -16.87% |
| December 31, 2023 | -32.79% |
| September 30, 2023 | 68.71% |
| June 30, 2023 | -296.2% |
| March 31, 2023 | -502.8% |
| December 31, 2022 | -66.24K% |
| September 30, 2022 | -38.10K% |
| June 30, 2022 | -6.82K% |
| March 31, 2022 | -3.42K% |
| December 31, 2021 | -4.02K% |
| September 30, 2021 | -4.22K% |
| June 30, 2021 | -5.08K% |
| March 31, 2021 | -11.43K% |
| December 31, 2020 | -232.2K% |
| September 30, 2020 | -229.4K% |
| June 30, 2020 | -139.2K% |
| Date | Value |
|---|---|
| March 31, 2020 | -134.5K% |
| December 31, 2019 | -104.1K% |
| September 30, 2019 | -163.0K% |
| June 30, 2019 | -95.30K% |
| March 31, 2019 | -92.52K% |
| December 31, 2018 | -141.7K% |
| September 30, 2018 | -89.34K% |
| June 30, 2018 | -116.2K% |
| March 31, 2018 | -109.3K% |
| December 31, 2017 | -81.00K% |
| September 30, 2017 | -82.77K% |
| June 30, 2017 | -74.61K% |
| March 31, 2017 | -72.97K% |
| December 31, 2016 | -62.14K% |
| September 30, 2016 | -65.17K% |
| June 30, 2016 | -41.73K% |
| March 31, 2016 | -36.35K% |
| December 31, 2015 | -46.23K% |
| September 30, 2015 | -35.84K% |
| June 30, 2015 | -44.89K% |
| March 31, 2015 | -38.26K% |
| December 31, 2014 | -49.33K% |
| September 30, 2014 | -45.80K% |
| June 30, 2014 | -31.46K% |
| March 31, 2014 | -19.81K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 45.94% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
| Cytokinetics, Inc. | -694.4% |
| Exelixis, Inc. | 33.73% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 81.19% |
| Return on Assets | 37.04% |
| Return on Invested Capital | 44.26% |
| Gross Profit Margin (Quarterly) | 82.86% |
| Operating Margin (Quarterly) | 9.02% |
| Return on Net Operating Assets | 94.58% |